Effect of L- type Calcium Channel Blocker Nimodipine and T-type Calcium Channel Blocker Flunarizine on Motor Control in Mice

Authors

Swapnil Balkrishna Kaikade

Department of Pharmacology,
ACPM Medical college
Nitin D. Pise

Department of Pharmacology,
ACPM Medical college

DOI:

https://doi.org/10.7439/ijpr.v5i5.2007

Abstract

Objective: To study the effect of L-type of Calcium channel blocker nimodipine and T-type of calcium channel blocker funarizine on locomotor activity in mice without pretreatment by any other drug.
Materials and method: The study was carried out following permission from the Institutional animal ethics committee. Healthy Swiss albino mice of either sex were selected by the strict inclusion and exclusion criteria and the grouping is done. Group A is control treated with normal saline, Group B and C received two titrated doses of nimodipine while Group D and E received two titrated doses of flunarizine. The animals were then observed for motor control on inclined plane and the Statistical analysis was done by using unpairedt test.
Results: L-type calcium channel blocker nimodipine has dose dependent effect on motor control on inclined plane while the T- type calcium channel blocker flunarizine has no effect on motor control.
Conclusion: Nimodipine has significant dose dependent depressant action on motor control on inclined plane while flunarizine has no effect on the above mentioned parameter.

Downloads

Download data is not yet available.

References

Fleckenstein A. Calcium Channel Blockers. Exper Facts and Therap Prospect. 1983.

Bretzel RG. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy. J Diabetes Complications. 1997;11: 112-122.

Tsien RW, Lipscombe D, Madison DV, Bley KR, Fax AP. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci 1988;11: 431-438.

Takahashi E, Niimi K. Modulators of voltage-dependent calcium channels for the treatment of nervous system diseases. Recent Pat CNS Drug Discov. 2009 Jun; 4(2): 96-111.

Mccleskey EW, Fox AP, Feldman DH, Cruz IJ, Olivera BM, Tsien RW, Yoshikami D. Omega-conotoxin: direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci.1987; 84: 4327-4331.

Geer JJ, Dooley DJ, Adams ME. K+-stimulated45Ca2+ flux into rat neocortical mini-slices is blocked by omega-Aga-IVA and the dual Na+/Ca2+ channel blockers lidoflazine and Flunarizine. Neurosci. Lett. 1993;158: 97-100.

Jack A. Grebb. Nifedipine and flunarizine block amphetamine-induced behavioral stimulation in mice. Life Sciences. 1986June;38(26): 2375-2381.

Published

2015-05-30

How to Cite

Kaikade SB, Pise ND. . Int J of Pharmc Res [Internet]. 2015May30 [cited 2020Jul.3];5(5):122-4. Available from: https://ssjournals.net/index.php/ijpr/article/view/2007

Issue

Vol. 5 No. 5 (2015): May

Section

Research Articles

Authors who publish with this journal agree to the following terms:

1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
4. Author must Submit Copyright form After acceptance of Article